Header cover image

Chinese (SSE) Biotech Industry Analysis

UpdatedApr 13, 2024
DataAggregated Company Financials
Companies73
  • 7D-2.7%
  • 3M-10.1%
  • 1Y-27.4%
  • YTD-15.6%

Over the last 7 days, the Biotech industry has dropped 2.7%, driven by a pullback from Chongqing Zhifei Biological Products of 9.6%. On the other hand Beijing Wantai Biological Pharmacy Enterprise is actually up 20%. Overall the industry is down 27% in 12 months. Earnings are forecast to grow by 35% annually.

Industry Valuation and Performance

Has the Chinese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 14 Apr 2024CN¥938.7bCN¥161.4bCN¥20.3b37.5x46.3x5.8x
Tue, 12 Mar 2024CN¥1.0tCN¥165.5bCN¥22.1b36.4x45.5x6.1x
Thu, 08 Feb 2024CN¥934.3bCN¥167.9bCN¥21.4b30.6x43.6x5.6x
Sat, 06 Jan 2024CN¥1.1tCN¥168.1bCN¥21.5b39x50.1x6.4x
Mon, 04 Dec 2023CN¥1.1tCN¥168.1bCN¥21.5b41.5x53.4x6.8x
Wed, 01 Nov 2023CN¥1.1tCN¥175.5bCN¥25.1b41.2x43.6x6.2x
Fri, 29 Sep 2023CN¥1.1tCN¥170.9bCN¥25.2b42.6x41.7x6.2x
Sun, 27 Aug 2023CN¥972.0bCN¥171.1bCN¥28.2b36.7x34.4x5.7x
Tue, 25 Jul 2023CN¥1.1tCN¥177.4bCN¥29.9b39.6x36x6.1x
Thu, 22 Jun 2023CN¥1.1tCN¥177.4bCN¥29.3b37.9x36.4x6x
Sat, 20 May 2023CN¥1.2tCN¥177.7bCN¥29.6b41.5x39.2x6.5x
Mon, 17 Apr 2023CN¥1.3tCN¥187.3bCN¥36.5b43.8x35.5x6.9x
Wed, 15 Mar 2023CN¥1.3tCN¥179.2bCN¥36.1b45.1x34.6x7x
Fri, 10 Feb 2023CN¥1.3tCN¥179.6bCN¥37.9b43.4x34.6x7.3x
Sun, 08 Jan 2023CN¥1.3tCN¥175.6bCN¥37.9b39.7x33.1x7.2x
Tue, 06 Dec 2022CN¥1.2tCN¥175.6bCN¥37.9b38.8x32.9x7.1x
Thu, 03 Nov 2022CN¥1.2tCN¥174.9bCN¥37.0b38.7x33.3x7x
Sat, 01 Oct 2022CN¥1.1tCN¥174.0bCN¥40.1b29.5x28.2x6.5x
Mon, 29 Aug 2022CN¥1.2tCN¥220.0bCN¥43.5b35.6x28.2x5.6x
Wed, 27 Jul 2022CN¥1.3tCN¥168.8bCN¥42.1b35.9x30.7x7.6x
Fri, 24 Jun 2022CN¥1.3tCN¥168.1bCN¥42.4b38.1x30.4x7.7x
Sun, 22 May 2022CN¥1.2tCN¥168.1bCN¥42.4b35.9x29.2x7.4x
Tue, 19 Apr 2022CN¥1.4tCN¥156.0bCN¥41.6b39x32.8x8.7x
Thu, 17 Mar 2022CN¥1.4tCN¥152.5bCN¥40.9b42.9x33.7x9x
Sat, 12 Feb 2022CN¥1.4tCN¥148.5bCN¥39.7b42.2x34.2x9.1x
Mon, 10 Jan 2022CN¥1.5tCN¥143.3bCN¥39.3b48.3x37.7x10.3x
Wed, 08 Dec 2021CN¥1.5tCN¥141.8bCN¥39.1b49.1x39.1x10.8x
Fri, 05 Nov 2021CN¥1.5tCN¥144.1bCN¥39.6b45.5x38.4x10.6x
Sun, 03 Oct 2021CN¥1.6tCN¥130.3bCN¥33.4b45.3x46.7x12x
Tue, 31 Aug 2021CN¥1.6tCN¥130.3bCN¥33.4b46.4x48.3x12.4x
Wed, 07 Jul 2021CN¥1.9tCN¥129.8bCN¥33.3b57.1x56.1x14.4x
Price to Earnings Ratio

66.5x


Total Market Cap: CN¥1.8tTotal Earnings: CN¥27.4bTotal Revenue: CN¥116.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Chinese Biotech Industry Price to Earnings3Y Average 40.3x202220232024
Current Industry PE
  • Investors are optimistic on the Chinese Biotechs industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 46.3x which is higher than its 3-year average PE of 40.3x.
  • The 3-year average PS ratio of 8.4x is higher than the industry's current PS ratio of 5.8x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have declined 9.6% per year over the last three years.
  • Meanwhile revenues for these companies have grown 12% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Chinese Healthcare industry?

CN Market-2.72%
Healthcare-3.01%
Biotech-2.70%
Biotech-2.70%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
603392 Beijing Wantai Biological Pharmacy EnterpriseCN¥77.1420.0%
+CN¥16.3b
-8.2%PE78.4x
688105 Nanjing Vazyme BiotechLtdCN¥29.0624.3%
+CN¥2.3b
-32.1%PS9x
600161 Beijing Tiantan Biological ProductsCN¥27.391.4%
+CN¥626.2m
-0.8%PE38.8x
688266 Suzhou Zelgen BiopharmaceuticalsLtdCN¥51.790.8%
+CN¥103.2m
-13.0%PS35.5x
300313 Xinjiang Tianshan Animal Husbandry Bio-engineeringCN¥7.992.6%
+CN¥62.6m
33.2%PS18.2x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

300676

CN¥38.64

BGI Genomics

7D

-5.6%

1Y

-48.7%

603392

CN¥77.14

Beijing Wantai Biological Pharmacy Enterprise

7D

20.0%

1Y

-8.2%

300896

CN¥289.86

Imeik Technology DevelopmentLtd

7D

-9.4%

1Y

-48.0%

300313

CN¥7.99

Xinjiang Tianshan Animal Husbandry Bio-engineering

7D

2.6%

1Y

33.2%

688266

CN¥51.79

Suzhou Zelgen BiopharmaceuticalsLtd

7D

0.8%

1Y

-13.0%

688363

CN¥53.00

Bloomage BioTechnology

7D

-5.6%

1Y

-52.0%

688105

CN¥29.06

Nanjing Vazyme BiotechLtd

7D

24.3%

1Y

-32.1%

2252

CN¥6.77

Shanghai RAAS Blood Products

7D

-4.0%

1Y

1.8%

300601

CN¥20.96

Shenzhen Kangtai Biological Products

7D

-5.7%

1Y

-38.3%

300122

CN¥40.94

Chongqing Zhifei Biological Products

7D

-9.6%

1Y

-25.8%